D. Galdermans

A phase Ib, dose-finding study of erlotinib in combination with a fixed dose of pertuzumab in patients with advanced non-small-cell lung cancer.

M. Ranson, E. Felip, S. Cedrés, 2012, Clinical lung cancer.

Gemzar (Gemcitabine) with thoracic radiotherapy- A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (NSCLC) [abstract]

P. Scalliet, A. Turrisi, H. Groen, 1998 .

Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study

J. V. van Meerbeeck, B. Hiddinga, A. Janssens, 2017, Clinical lung cancer.

Long-Term Disease Control of a Non-Operable Neuroendocrine Tumor of the Lung with Lanreotide: A Case Study

D. Galdermans, D. Schrijvers, V. De Ruyter, 2012, Case Reports in Oncology.

Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy.

R. Sheorajpanday, W. Van de Sompel, D. Galdermans, 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)

J. V. van Meerbeeck, J. Canon, Y. Humblet, 2016, PloS one.

Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter Study.

J. V. van Meerbeeck, A. Janssens, D. Galdermans, 2019, Clinical lung cancer.

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

R. Greil, O. Popovych, C. Gridelli, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Acute Oligo‐Anuria During Ovarian Hyperstimulation Syndrome

L. Bossaert, G. Verpooten, H. Demey, 1987, Acta obstetricia et gynecologica Scandinavica.

A phase Ib, dose-finding study of erlotinib in combination with a fixed dose of pertuzumab in patients with advanced non-small-cell lung cancer.

M. Ranson, E. Felip, P. Martínez, 2012, Clinical lung cancer.